Ed Fritsch
ACIR | DionisTx | Personal Cancer Vaccines
- Role
- Co-founder at Ucir
- Location
- Concord, MA, US
- LinkedIn followers
- 500 followers
About Ed Fritsch
Experienced biopharmaceutical executive with a long and productive history in the biotechnology industry. Skilled in Molecular Biology, Biotechnology, Drug Discovery, and Drug Development. Co-author of \"Molecular Cloning: A Laboratory Manual\", considered the \"bible\" that helped spread the application of recombinant technlogy worldwide during the explosive growth of the field during the 1980\'s. Strong recent interest in the breakthrough field of cancer immunotherapy, particularly the development of neoantigen-based personal cancer vaccines (see Nature [2017] 547:7622 \"An immunogenic personal neoantigen vaccine for patients with melanoma\"). Co-founder of Accelerating Cancer Immunotherapy Research (a 503(c)(b) not-for-profit organization) and Neon Therapeutics, Inc.Undegraduate Bachelor of Science (BS) in Biology from the Massachusetts Institute of Technology and a Doctor of Philosophy (PhD) focused in Molecular Biology from University of Wisconsin.
Experience
Co-founder
Jan 2020 — Present · Concord, MA, US
Education
University of Wisconsin
Doctor of Philosophy (PhD), Molecular Biology
1973 — 1978
MIT
Biology
1968 — 1972
Skills
- Technology Transfer
- Drug Discovery
- Biotechnology
- Immunology
- Clinical Development
- Pharmaceutical Industry
- Protein Chemistry
- Drug Development
- Biopharmaceuticals
- Life Sciences
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.